EAPHARMA
Live / Applied — Suspended — suspension check completed, case still suspended (as of 09 Dec 2025)
What this means for you
Not registered yet, but its 19 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98365237
- Mark type
- Design + words
- Filed
- 19 Jan 2024
- Attorney of record
- Matthew L. Frisbee
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, inflammatory, namely except inflammatory bronchial disease, metabolic, neurodegenerative, neurological, psychiatric, oncological, and viral diseases and disorders; Pharmaceutical preparations for the treatment of liver diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain, and diabetes; Reagent paper for medical purposes
- Class 042 — Scientific and technological services: Pharmaceutical research and development, namely, pharmaceutical testing, inspection and research
- Class 044 — Medical, beauty and agricultural services: Medical information; Providing health care information via a global computer network
Owner
- EA Pharma Co., Ltd., Tokyo, JP
Prosecution history
- 09 Dec 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 17 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Jun 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 19 Nov 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 19 Nov 2024 — LETTER OF SUSPENSION E-MAILED
- 19 Nov 2024 — SUSPENSION LETTER WRITTEN
- 25 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Oct 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Aug 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Aug 2024 — NON-FINAL ACTION E-MAILED
- 14 Aug 2024 — NON-FINAL ACTION WRITTEN
- 14 Aug 2024 — ASSIGNED TO EXAMINER